MD Anderson’s Moon Shots Program has expanded its targets, adding some of the most intractable cancers to its campaign to more rapidly convert scientific discoveries into life-saving advances.
The innovative program’s transdisciplinary team-science approach and transformative professional platforms now pursue meaningful progress against B-cell lymphoma, glioblastoma (brain cancer), HPV associated cancers (caused by the human papilloma...
It’s been a year since CVS Pharmacy, the nation’s second largest chain of drugstores, stopped selling tobacco, and the company claims the...
For the first time, a new drug from the field of immuno-oncology has proven to extend survival for patients with advanced kidney cancer, a...
A vaccine that delivers an antigen to dendritic cells, in turn activating killer T cells that can target specific cancers, is being investigated in two ongoing clinical trials.
The first trial began enrolling patients with locally advanced or metastatic sarcoma, melanoma, ovarian cancer, non-small cell lung cancer, or breast cancer last year. To be eligible, patients’ biopsies had to show NY-ESO-1 expression in at least 5% of tumor...
Patients who undergo surgery are recovering faster and getting discharged sooner thanks to MD Anderson’s enhanced surgical recovery programs...
Rafael Pantoja had all but lost hope.
The thyroid cancer he had battled for 14 years was back and spreading.
Then, earlier this...
A drug for pancreatic cancer that is also used to prevent rejection of organ transplants has been shown to delay progression of another form...
A career-long fascination with discovering the ins and outs of T cells, our immune system’s tailor-made destroyers of infections and dysfunctional...